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Abstract
The derivation of induced human pluripotent stem cells (hiPS) has generated significant enthusiasm particularly for the
prospects of cell-based therapy. But there are concerns about the suitability of iPS cells for in vivo applications due in part to
the introduction of potentially oncogenic transcription factors via viral vectors. Recently developed lentiviral vectors allow
the excision of viral reprogramming factors and the development of transgene-free iPS lines. However it is unclear if
reprogramming strategy has an impact on the differentiation potential and the in vivo behavior of hiPS progeny. Here we
subject viral factor-free, c-myc-free and conventionally reprogrammed four-factor human iPS lines to a further challenge, by
analyzing their differentiation potential along the 3 neural lineages and over extended periods of time in vitro, as well as by
interrogating their ability to respond to local environmental cues by grafting into the striatum. We demonstrate similar and
efficient differentiation into neurons, astrocytes and oligodendrocytes among all hiPS and human ES line controls. Upon
intracranial grafting in the normal rat (Sprague Dawley), precursors derived from all hiPS lines exhibited good survival and
response to environmental cues by integrating into the subventricular zone, acquiring phenotypes typical of type A, B or C
cells and migrating along the rostral migratory stream into the olfactory bulb. There was no teratoma or other tumor
formation 12 weeks after grafting in any of the 26 animals used in the study. Thus neither factor excision nor persistence of
c-myc impact the behavior of hiPS lines in vivo.
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Introduction
The derivation of human iPS cells [1,2] is a major advance for
biomedical research including cell-based therapies. However there
have been several concerns about the suitability of iPS cells for in
vivo applications. Those include a risk of insertional mutagenesis
or point mutations in protein-coding regions [3] following the use
of integrating vectors, aberrations in epigenetic reconfiguration [4]
or incomplete silencing of transgenes with reactivation of
potentially oncogenic factors such as c-myc [5]. In addition,
questions pertaining to the differentiation potential and in vivo
behavior of iPS cells, compared to human ES cells remain
unresolved. While iPS cells closely mimic the properties of ES
cells, recent studies in the mouse have shown differences in
epigenetic state [6,7] related to cell of origin. Other investigations
using the reprogrammable mouse system showed differences in the
expression of specific imprinted genes [8] that were correlated with
the ability of the cells to contribute to chimeric mice in vivo. A
number of studies also showed differences in gene expression
between iPS and ES cells, though some of those alterations might
be due to residual transgene expression in the resulting iPS cells
[9]. A recently developed doxycycline-inducible lentiviral vector
system enables transgene excision by Cre-recombinase resulting in
transgene-free iPS lines [9]. The lines and specific clones used here
have been published and fully characterized by Soldner et al. [9],
including an assessment of their pluripotency via factor expression
and teratoma formation; their karyotype was also shown to be
normal. Interestingly, gene expression studies demonstrated
significant differences between excised versus non-excised iPS cell
lines with the excised clones more closely matching the gene
expression profiles of ESC lines[9]. In this work, we focus on the in
vivo behavior of iPS progeny, taking advantage of the availability
of iPS lines that are derived from the same fibroblast source and
that differ by the ability of actively excising the reprogramming
transgenes.
We subjected iPS clones derived, via several reprogramming
strategies, from a single fibroblast line (+/2 c-myc, excised or non-
excised transgenes), to neural induction and differentiation along
neuronal, astrocytic and oligodendroglial lineages. Comparisons
were established side-by-side with a well-characterized ES line
(H9, WA-09). We also asked whether the persistence of viral factor
expression could impact more complex interactions of human iPS
progeny with the host brain microenvironment in vivo. Using a
previously established transplantation paradigm [10] we compared
the potential of human neural precursors derived from excised
versus non-excised iPS or from control ES cell lines for in vivo
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integration into the adult rat SVZ and the ability to contribute
human cells to the rostral migratory stream and olfactory bulb. Of
particular interest was the question of whether residual expression
of c-myc might induce excessive proliferation or even promote
neoplastic transformation in vivo. Using viral transgene factor-
free, c-myc-free and conventionally reprogrammed four-factor
human iPS lines, we observed a comparable differentiation
potential along the 3 major neural lineages in vitro, including
the derivation of oligodendrocyte and astrocyte lineages. Similarly,
the in vivo study demonstrated that neural precursors are capable
of responding to local environmental cues by integration into the
adult brain subventricular zone (SVZ) independently of transgene
excision. These data suggest that carefully validated iPS cell clones
are suitable for in vitro and in vivo iPS cell differentiation and for
transplantation studies independent of transgene excision.
Results
Neural induction in iPS cells
Induced pluripotent stem cell (hiPSC) lines were generated from
a single source of dermal fibroblasts (AG20442) as described
previously[9]. In brief, the lines used in the current study include
PDB4F-2 and PDB3F-5 which were derived using doxycycline
(DOX)-inducible lentiviruses carrying OCT4, SOX2, KLF4 with
(4F) or without c-myc (3F). An additional pair of hiPS lines
represents a parental line reprogrammed using 3 non-excised
factors (no c-myc; PDB2lox-21) and its derivative, subjected to Cre-
recombinase mediated excision of reprogramming factors
(PDB1lox-21-12). Absence of residual factors in the excised lines
was confirmed by Southern blot. The human ES line, H9 (WA-
09), was used as a control.
Immunocytochemical analysis of the pluripotency markers
showed uniform expression of Nanog, Oct4, Tra1-60 as well
SSEA-4 in all hiPSC and H9 lines (Fig. S1A). Neural induction
and rosette formation was performed under serum-free conditions
by coculture on a stromal cell line (MS5) [11] in the presence of
Noggin [12]. Rosettes were harvested mechanically on day 10 of
differentiation and replated on culture dishes precoated with
polyornithine/laminin in N2 media supplemented with growth
factors (P1 rosette stage) (Fig. 1A). Mechanical isolation of rosettes
was repeated after seven days (P2 rosette stage). This process
selects for clusters of CNS (Central Nervous System) progenitors
and greatly depletes the cultures of neural crest precursors. A
second selection is performed 15 days later and neural precursor
cells (NPCs) are subsequently cultured and passaged for an
additional 3 weeks. At day 50 of differentiation, immunocyto-
chemical analysis reveals that .90% of cells were immunoreactive
to nestin and Pax6 (Fig. S1B) in all four iPS lines tested as well as
the hES control. Immunoreactivity to Ki-67 (44% 61.7)
demonstrated a high proliferative capacity among young neural
precursors, comparable across the five lines used (p.0.5). These
data suggest that neural induction and neural precursor cell
proliferation are not impacted by excision of reprogramming
factors or the absence of c-myc.
Differentiation potential along the three neural lineages
Previous studies have assessed the potential of human ES cell
and iPS cells to undergo neural and neuronal differentiation in
vitro [13] and the differentiation towards neurons expressing
dopaminergic markers [14]. Here we extended those studies to
address whether neuronal as well as glial lineages can be derived at
comparable efficiencies from excised and non-excised iPS cells and
from human ES cells. Neuronal differentiation was induced by
withdrawal of EGF/FGF2 and exposure to brain-derived
neurotrophic factor (BDNF) and ascorbic acid (AA) for three
weeks which resulted in a high yield (.90%) of NeuN+/Tuj1+
neurons. Oligodendrocyte differentiation, as assessed by the
expression of surface antigen O4 and appropriate morphology,
was induced in the presence of BDNF, AA, PDGFR-AA, sonic
hedgehog, FGF-8 and cAMP for six weeks following EGF/FGF2
withdrawal. Quantification of glial phenotypes showed that hES as
well hiPS derived NPCs were similarly competent and efficient
(56.5% 61.9) in acquiring oligodendrocyte identity (Fig. 1B, C).
For directed differentiation towards an astrocytic fate, NPCs from
each of the lines were differentiated in medium containing 5%
FBS, for six additional weeks. Again, equal astrocytic potential
across all five tested lines was observed by immunocytochemistry
for glial fibrillary acidic protein (GFAP, 91.7% 61.46) (Fig. 1B,
C). Thus, neither the number of reprogramming factors used nor
their excision impacted in vitro differentiation potential. Further-
more, these hiPS lines exhibited a similar temporal course and
capacity for neuro-epithelial, neuronal and glial cell specification,
in comparison to human ES cells.
Tranpslantation in the subventricular zone
We subsequently performed in vivo experiments in order to
further define a potential impact of reprogramming strategy on in
vivo function. We were particularly interested in exploring the in
vivo differentiation behavior of iPS and hES cell derived neural
precursors. While previous studies have assessed the in vivo
survival of pre-differentiated dopamine neuron precursors, here
we analyze the site- specific in vivo integration and differentiation
potential of naı¨ve neural precursor cells. The response to in vivo
environmental cues may be a more sensitive parameter to address
the impact of transgene excision and to compare the behavior of
iPS and ES cell progeny.
An identical number of NPCs (day 50 in vitro) from each of the
hiPS and control lines was stereotactically transplanted into the
striatum of adult rats. The animals (n = 20) received a 3-day course
of systemic BrdU two weeks post grafting, and were sacrificed at
12 weeks. All surviving animals exhibited a live graft consisting of a
core and a large number of migrating cells. Graft volumes as
determined by stereological analysis (StereoInvestigator, MBF
Bioscience, VT) ranged from 0.95 to 2.8 mm3 (Fig. 2A). The total
cell number within the grafts averaged 1.5 6106 cells (Optical
fractionator, range 0.95–2.56106 cells) (Fig. 2B). One way
ANOVA analysis did not demonstrate a statistically significant
difference among the volumes and cell counts of the five different
groups (p.0.5).
The migration pattern of individual cells was captured by
NeuroLucida drawings. Human cells were identified using human
nuclear antigen (hNA) or human neural cellular adhesion marker
(NCAM) expression. They were distributed ipsi-and contra-
laterally in the corpus callosum, but the majority of the cells
injected traveled forward along the rostral migratory stream into
the olfactory bulb, suggesting a response to local subventricular
zone cues (Fig. 2C) [15]. There were no differences in migratory
patterns among the lines used. To further elucidate the non-
random nature of this migratory behavior, we established
oligodendrocyte precursor cultures from the H9 line (OPCs, as
described above) that were subjected to a FACS sort for O4. O4+
cells were further characterized by the expression of olig2, thus
confirming their oligodendroglial identity (Fig. S2). The sorted
cells were injected at the same coordinates and the animals
sacrificed at 12 weeks (n = 6). The migration routes exhibited by
the O4 cells were very distinct from those of the naı¨ve neural
precursor cells and specifically followed the white matter pathways
along the corpus callosum and the internal capsule. In contrast to
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Figure 1. Derivation of neural lineages from hES and iPS cells. (a) Schematic representation of the neural differentiation protocol. Phase
contrast images of at different stages of neural induction and expansion. (b) Immunofluorescence labeling of neurons (TuJ1/NeuN), astrocytes (GFAP)
and oligodendrocytes (O4) following differentiation. (c) Quantification of neurons, astrocytes, and oligodendrocytes derived from human iPS and ES
lines. Scale bars 100 mm in a and 20 mm in b. Errors are SD; n = 3 experiments.
doi:10.1371/journal.pone.0024687.g001
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the neural precursor cell grafts there were only very few cells
traveling along the RMS. The cell migration paths are illustrated
in representative camera lucida drawings (Fig. 3A).
In vivo phenotypes
The core grafts in all the experimental and control groups were
mainly located in the striatum, with small clusters occasionally seen
around the corpus callosum. Most of the cells in the core expressed
the human markers, human nuclear antigen or human NCAM, were
neuronal precursors expressing neuron-specific class III beta-tubulin
(Tuj1) as well doublecortin (Dcx)+,(.60%) (Fig. 3B, upper panel). A
smaller population of glial cells recognized by expression of the NG2
chondroitin sulfate proteoglycan was also observed. GFAP+ human
cells were rare and mostly located in the periphery of the core graft
(,1%). Host GFAP+ cells were found along the injection site.
Human cells that were located away from the core acquired
phenotypes typical of the local environment. Human iPS- as well
control-derived neural precursors exhibited region specific immuno-
histochemical profiles, and integrated along the SVZ, giving rise to
the three SVZ niche phenotypes [16]. A small proportion of human
cells were identified within the ipsilateral and contralateral SVZ
where they expressed markers characteristic of the activated type B
stem cell population (EGFR+/GFAP+) or type C transit amplifying
cells (EGFR+/Dlx2+) [17] (Fig. 3B, middle panel). A majority of
Figure 2. In vivo behavior of hES and hiPS derived neural precursors. (a) Graphic representation of the volumes of hiPS- and hES-derived
grafts. (b) Cell numbers in the core grafts. (c) Migratory behavior of transplanted neural precursors (labeled for human nuclear antigen, hNA, in red).
Core grafts from all lines are in the striatum while the majority of cells traveled along the rostral migratory stream (RMS) reaching the olfactory bulb
(OB). Scale bars, 100 mm. Errors are SD; total animal number = 20.
doi:10.1371/journal.pone.0024687.g002
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cells however exhibited a type A or migrating neuroblast phenotype,
labeling for CD24, PSA-NCAM and Dcx (Fig. 3B, middle panel) as
they travelled anteriorly along the RMS. Human cells could be seen
at the distal RMS, entering the olfactory bulb, whereby a few cells
(,1%) migrated to the granular and periglomerular layers. These
cells differentiated into calretenin or calbindin periglomerular
interneurons, or c-aminobutyric acid (GABA) expressing granular
interneurons (Fig. 3B, lower panel). The number of cells exhibiting
interneuron phenotypes was very small (one or two per section) but
identical among all hiPS and hES lines used and similar to previously
reported data with human ES cells [10] and primary fetal neural
progenitors [18]. This region-specific immunohistochemical profile of
human cells is identical to that exhibited by endogenous SVZ stem
cell progeny and was demonstrated in all 4 hiPS clones and hES line
used, as shown in Figure 2 (cell of origin is indicated in the legend). All
co-localisations were confirmed by serial 3D reconstruction of
confocal sections. No human cells were found in other regions of
the olfactory lobe, suggesting that they reached the olfactory bulb
selectively by the RMS route rather than by random migration.
There was also an absence of neuronal differentiation outside the core
graft and the RMS/olfactory area. In contrast the transplanted
oligodendrocyte precursors formed a smaller core and exhibited
migration along the corpus callosum without any evidence of
integration in the SVZ or expression of markers suggestive of SVZ
stem cell progeny (Figure S2). The OPCs did not reach the olfactory
bulb in any of the animals injected.
The immunohistochemical profile of the neural precursors prior
to transplantation demonstrates immunoreactivity to nestin and
Figure 3. In vivo migration patterns and graft immunohistochemical profiles. (a) Representative camera lucida drawings of core grafts and
migrating cells, highlighting that OPC grafts were confined to the white matter tracts while NPCs migrated to the RMS and the OB. (b) Within the
graft cores, cells were predominantly neuronal expressing doublecortin (Dcx; PDB4F-2) and TuJ1(PDB3F-5). Migrating cells in the corpus callosum were
immunopositive for CD24 (PDB2lox-21) and a smaller proportion labeled for NG2. In the SVZ, grafted cells acquired region-specific phenotypes: type A
cells (EGFR/CD24; PDB1lox-21-12), type B cells (EGFR/GFAP; PDB3F-5) as well transit amplifying type C cells (EGFR/Dlx2; PDB2lox-21). Within the olfactory
bulb (OB) rare human cells exhibited an interneuron phenotype, expressing calretinin (PDB3F-5) or GABA (PDB4F-2). Scale bars, 20 mm. hNCAM =
human-specific neural cell adhesion molecule; hNA= human nuclear antigen.
doi:10.1371/journal.pone.0024687.g003
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TuJ but not EGFR, Dlx2, and CD24 (Figure S3). Similarly the
oligodendrocyte progenitors were immunopositive for O4 and
olig2 but did not exhibit any SVZ markers. These data suggest a
significant cell-autonomous response exhibited specifically by cells
at the neural stage in response to environmental cues.
Proliferation in vivo
The BrdU regimen involved pulse labeling ten weeks prior to
sacrifice followed by a chase period for the remainder of the time,
allowing identification of label retaining cells and neurons born in
vivo. Concomitant labeling with Ki67 allows us to determine the
actual rate of proliferation in vivo following graft integration. All
five lines tested exhibited BrdU retention and a similar percentage
of BrdU+ cells in the graft core (average 19.9% 66.6; range: 17–
23%; calculated stereologically via optical fractionator)[19]
(Fig. 4A). The predominant phenotype of the BrdU positive cells
in the core graft was neuronal (Fig. 4B). In the SVZ, the highly
proliferative transit amplifying C cells were BrdU negative
indicating label dilution. A few human cells residing in the SVZ
retained BrdU and co-expressed EGFR, compatible with the
slowly dividing type B stem cells. The BrdU label was also retained
by the neuroblasts traveling to the RMS (Fig. 4B). All grafts from
the experimental and control groups exhibited a proliferation
capacity of less than 1% as shown by Ki-67 staining (Fig. 4A),
indicating that most cells stopped dividing 12 weeks post grafting,
despite an initial period of proliferation as indicated by the BrdU
labels. None of the grafted animal brains harbored a teratoma
(absence of alpha-fetoprotein, cytokeratin, myosin) or other type of
tumor as assessed by histological analysis on hematoxylin and
eosin (H&E) sections.
Discussion
Reprogramming strategies have evolved rapidly, including the
use of micro-RNA [20], non-integrating vectors [21–24], mRNA
[25], protein [26,27] or small molecules [28] in lieu of viral
transgenes, or microenvironmental modifications to induce
endogenous genes [29]. However reprogramming efficiency via
most of these methods is extremely low, in the range of 0.001%.
The use of integrating vectors offers a relatively more efficient
means of reprogramming but also raises safety concerns with the
subsequent risk of genetic and epigenetic aberrations [3,4], the
overexpression of proliferation- and potentially neoplasm-associ-
ated genes such as c-myc[30] and the incomplete silencing of
reprogramming factors following differentiation[5]. Such issues
would constitute barriers to the clinical use of iPS progeny [31]. In
fact, transmission of iPS clones through the germ line in mice has
resulted in tumor formation in 20% of the chimeric progeny,
probably due to reactivation of the c-myc transgene [32]. The use
of doxycycline-inducible vectors allows greater control over
transgene expression but does not eliminate the possibility of
residual transgene expression, due to leaky promoters. Thus
several groups have introduced integrating vectors that incorpo-
rate loxP sites allowing their excision via Cre recombinase once
pluripotency is achieved [33–35] [9]. Such systems provide the
advantages of integrating vectors and higher reprogramming
efficiency while allowing for definitive elimination of full transgene
expression. Short sequences of vector DNA however remain
integrated in the host genome with the potential to interfere with
normal function [36].
Despite the rapid evolution of reprogramming strategies, their
impact on the potential of iPS cells to stably differentiate along
specific lineages has not been extensively studied. Recent literature
has reported variable ‘‘innate’’ propensity of ES and iPS lines for
preferential differentiation along different lineages [37], as well as
interline differences in efficiency of neural induction [13]. Other
investigators have suggested that factor-based reprogramming can
leave an epigenetic memory of the tissue of origin that may impact
directed differentiation [6]. Our data however demonstrate robust
neural induction and differentiation into neural and glial lineages,
comparable in human ES and iPS lines. This suggests that
‘‘innate’’ differentiation propensity may be related, at least in part,
to variations in the specific culture protocols used. A more recent
report suggests a similar range of capacity towards motor neuron
differentiation [38] in a set of iPS lines derived from 7 different
sources, and yet another publication identifies a role for miR-371-
3 in specifying the propensity towards neural differentiation [39].
Differentiation along glial lineages is an important tool in
disease modeling particularly when non-cell autonomous factors
are significant contributors to disease phenotype as is the case in
ALS [40,41], or in cell-based approaches to remyelination. High
yield derivation of astrocytes or oligodendrocytes has not been
reported to date from human iPS cells. Here, we demonstrate the
generation of high percentages of astrocytes (.90%) and
oligodendrocytes (.50%) in vitro from all ES and iPS clones
presented. The protocols used are based on previously published
methods [11], and emphasize the selection of CNS precursors at
the expense of neural crest progeny. This is a crucial step in
ensuring a higher yield of glial progeny since neural crest
derivatives are highly proliferative competitors in culture.
However this rate-limiting step relies on mechanical selection
based on morphological criteria, and is thus operator-dependent.
Ongoing efforts aim to optimize this component of the
differentiation protocols, by substituting small molecules or
marker-based selection of the cells of interest. Once the cultures
are enriched in neural precursors, astrocyte differentiation is
achieved via mitogen withdrawal and the addition of serum over
several weeks. Oligodendrocyte production is highly dependent
upon the elimination of exogenous bFGF and maintaining high
concentrations of sonic hedgehog and FGF-8. These protocols
exhibit a high reproducibility rate and have in fact led to
comparable results among excised and non-excised clones.
Remarkably all iPS clones exhibited a profile highly similar to
that seen in H9, a well-characterized ES line with a significant
neural propensity. Thus reprogramming strategy such as excision
of viral transgenes, inclusion of c-myc did not impact in vitro
differentiation of human iPS cells along neurons and glia.
Obviously this study does not compare multiple lines but is
focused specifically on the role of factor excision in lines that
exhibit the same background.
The in vivo behavior of iPS cells has not been studied
extensively to date. Here we grafted hES and hiPS derived neural
progenitors in the adult brain and analyzed their ability to interact
with a complex in vivo microenvironment. While the factors that
control the cells’ response to cues emanating from the SVZ are not
well defined, previous experiments using human fetal neural
precursors or hES progeny have demonstrated a remarkable
ability for a fraction of cells to integrate that niche. Cells have
acquired a neuroblast or a transient amplifying cell phenotype
and, very infrequently, a stem cell phenotype that retained BrdU
label up to 10 weeks. The human iPS-derived neural precursors
also followed the SVZ-olfactory bulb migratory pathway, giving
rise to more differentiated neurons and reaching the olfactory
glomeruli. Olfactory neurogenesis in the rat is an inefficient
phenomenon, with large numbers of cells generated in the SVZ
but a very rare percentage incorporating the olfactory glomeruli
and differentiating into interneurons. In comparison, human iPS-
derived oligodendrocyte precursors followed the white matter
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along the corpus callosum and did not engage along the RMS or
reach the olfactory bulb, suggesting that response to the SVZ
niche is in part cell-autonomous. Importantly, the SVZ niche
phenotypes exhibited by the iPS derived NPCs were acquired in
vivo, likely in response to the local environment.
Other important data points include the absence of excessive
proliferation regardless of c-myc status. As expected, NPCs exhibit
significant proliferation shortly after transplantation as shown by
BrdU retention within the graft core. When examined 12 weeks
after grafting, however, proliferation had decreased dramatically
as demonstrated by the rare Ki67 expression. More importantly
there were no differences in survival, SVZ integration and
migration along the RMS and neuronal differentiation among
the hiPS lines, all 4 of which behaved similarly to the human ES
line. The lines used in this study have also been differentiated into
dopamine neurons by Jaenisch and colleagues and transplanted in
rat models of Parkinson’s disease with modest survival and some
behavioral amelioration [14].
Our data suggest low probability of transgene reactivation or
neoplastic transformation via the use of doxycycline-inducible
lentiviral vectors to deliver reprogramming transgenes. The
inclusion of c-myc in reprogramming did not result in altered
proliferative behavior in vitro or in vivo. In addition, Cre-
mediated excision did not have a definitive impact on differen-
tiation potential or in vivo behavior of iPS neural progeny.
However, more sensitive in vivo paradigms and outcome
parameters or longer term studies may be necessary to detect
more subtle differences. It is also conceivable that higher levels of
transgene expression as in non-inducible vectors may highlight
subtle differences among cell lines.
Reprogramming strategies, such as the specific transgenes used,
their copy number or their excision had no impact on the ability of
hiPS cell progeny to respond to in vivo cues and to acquire regional
phenotypes within the adult brain. Neither the use of c-myc in
reprogramming nor its excision impacted the proliferation rate or
graft size of human iPS progeny in vivo. This result cannot rule
Figure 4. Cell proliferation within the grafts. (a) Quantification of BrdU and Ki67 positive cells in the core grafts from hiPS and hES lines.
Representative immunohistochemical labeling for BrdU (PDB3F-5) and Ki67 (PDB4F-2). (b) BrdU label retention and Ki67 within the graft core, SVZ
and RMS. In the core graft BrdU label was mainly found in the neuronal cells (BrdU/NeuN; PDB2lox-21). In the SVZ BrdU was mostly retained by the
type B cells (BrdU/EGFR; PDB4F-2) while in the RMS some of the migrating neuroblasts (BrdU/CD24-PDB3F-5) are BrdU positive. Ki67 labeling was very
low in all regions. Scale bars, 20 mm. Error bars are SD; n= 20.
doi:10.1371/journal.pone.0024687.g004
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out that stronger transgene expression would affect in vivo
behavior as might be the case with other delivery systems or
non-inducible vectors. The use of a single fibroblast source does
allow for a clear comparison of the impact of transgenes but future
studies will need to address this issue across additional lines.
Methods
All animal experiments were done in accordance with protocols
approved by our Institutional Animal Care and Use Committee
(IACUC) and following the National Institutes of Health (NIH)
guidelines for animal welfare. The study was also approved by our
institutional Ethics committee (ESCRO) under Protocol 2009-06-
005.
Cell culture
Undifferentiated hES (H9 (NIH code: WA09; Wisconsin
Alumni Research Foundation, Madison, WI) and hiPS cells
(PDB4F-2, PDB3F-5, PDB2lox-21, PDB1lox-21-12) were cultured
under growth conditions as described previously [42] on
mitotically inactivated mouse embryonic fibroblasts (MEFs;
GlobalStem, Rockland, MD). The iPS lines were derived from
fibroblasts obtained from the Coriell Repository (AG20442;
Coriell Institute for Medical Research, Camden, NJ) by Soldner
et al [9]. The derivation of the lines as well as the lentiviral vector
design and cre-mediated excision are described in detail in Soldner
et al. [9]. For neural induction, hES cells were plated on a
confluent layer of irradiated stromal cells (MS-5) in knock-out
serum replacement (KSR, Invitrogen) medium supplied with
Noggin (250 ng/ml). Medium was changed every two days until
day 8, when Noggin was replaced with mouse supersonic
hedgehog (msSHH, 20 ng/ml) and Fibroblast growth factor
(FGF8, 100 ng/ml). All growth factors were purchased from
R&D Systems, Minneapolis, MN. Rosette structures were
harvested mechanically at day 10 of differentiation (termed
Passage 0; P0) and gently replated on 15 mg/ml polyornithine/
1 mg/ml Laminin (Po/Lam) coated culture dishes in N2 medium
(termed Passage 1; P1). Medium was changed every 2 days, and
was supplemented with growth factors as follows: 20 ng/ml
msSHH, 100 ng/ml FGF8, 20 ng/ml brain-derived neurotrophic
factor (BDNF) (all R&D Systems), and 0.2 mM ascorbic acid
(AA)[11] (Sigma–Aldrich, St Louis, MO). After 7 days of P1
culture, rosettes were re-picked and re-plated on Po/Lam coated
dishes and kept for an additional week in N2 media containing
BDNF, AA and msSHH (termed Passage 2; P2). At the end of the
P2 stage, cells were exposed to Ca2/Mg2-free Hanks balanced salt
solution (CMF-HBSS) for 20 min at 25uC and spun at 200 g for
5 min. The cell pellet was gently resuspended in N2 media and
plated on PO/lam coated dishes (termed Passage 3, P3). Starting
with P3, neural precursor cells (NPCs) were maintained in N2
medium supplemented with 20 ng/ml of fibroblast growth factor 2
(FGF2) and 20 ng/ml of epidermal growth factor (EGF) that was
changed every 2 days. As of this stage, the cells will loose rosette
formations and form clusters of neural progenitors interspersed
among flat cells. The cultures are subsequently passaged at least
twice by manual picking of the clusters of central nervous system
(CNS) precursor cells. This mechanical purification step ensures
the generation of cells highly enriched in CNS precursors and
largely devoid of neural crest lineages. Transplanted cells are
harvested at this stage.
For neuronal differentiation hES cell-derived CNS NPCs, were
subjected to EGF/FGF2 withdrawal at day 50, and cultured for an
additional three weeks in N2 media containing BDNF(20 ng/ml)
and AA (0.2 mM). For astrocyte differentiation, hES cell-derived
NPCs were kept six weeks in N2 media supplemented with 5%
Fetal Bovine Serum (FBS, Invitrogen), after mitogen withdrawal.
For oligodendrocyte differentiation, after EGF/FGF2 removal,
hES cell-derived NPCs were cultured for an additional six weeks in
N2 media that contained BDNF (20 ng/ml), AA (0.2 mM),
msSHH (100 ng/ml), Fibroblast growth factor (FGF8, 100 ng/
ml), Platelet-derived growth factor-AA (PDGF-AA, 20 ng/ml) and
dibutyrilic 39-59-cyclic adenosine monophosphate, (dbcAMP,
0.2 mM).
For the transplantation of the oligodendrocyte precursor cell
(OPCs) population, 100- day old NPCs were dissociated with
Accutase (Innovative Cell Technologies, San Diego, CA) and
subjected to FACS using O4 antibody (1:200; Millipore, Billerica,
MA) on a MoFlo flow cytometer (Cytomation, Fort Collins, CO).
Animal surgery
Young adult Sprague Dawley female rats (3 months old at time
of grafting, n= 26) were acquired from Taconic and used
throughout the study. Stereotactic intracranial transplantation of
graft cells was performed under full anesthesia using a mixture of
ketamine and xylazine (Hospira, Lake Forest, Illinois/Inc/Ben
Venue Laboratories). For all the implants, the animals received a
unilateral 1 ml (250,000 cells in sterile HBSS) injection at the
following coordinates: striatum: anteroposterior, + 1.6; mediolat-
eral, -1.5; ventral, - 4.2; tooth bar, -2.3. All coordinates relative to
bregma and ventral coordinates relative to cortex.
Immunosuppression
All rats received cyclosporine (Neoral 100 mg/ml; Novartis,
Basel, Switzerland) at 20 mg/kg/day intraperitoneally. This
regimen was initiated 1 day before grafting and maintained until
the animals were sacrificed, 12 weeks following transplantation.
BrdU administration
The BrdU (Sigma-Aldrich) regimen consisted of two doses of
BrdU at 150 mg/kg administered every 12 h for a total of 2 doses
over 3 days. This regimen was initiated 2 weeks after
transplantation in the SVZ. The animals (n = 26) were sacrificed
10 weeks after the administration of BrdU. BrdU was dissolved in
sterile normal saline and .007 M NaOH.
Tissue processing
Rats were deeply anesthetized with a 25-mg intraperitoneal
injection of pentobarbital solution (Nembutal Sodium Solution,
Abbott Laboratories Abbott Park, IL). This was followed by
transcardial perfusion with 10% Sucrose saline at 4uC (Aldrich-
Sigma) followed by 4% paraformaldehyde (PFA) in PBS also at
4uC (pH 7.4). The brains were carefully extracted, post-fixed
overnight in 4% PFA at 4uC, and subsequently transferred to 30%
sucrose at 4uC until embedding. Optimal cutting temperature
compound (O.C.T. Compound, Tissue-Tek, Sakura Finetek,
Torrance, CA) was used to embed the brains and sections were
cut on a freezing cryostat and stored at 280uC.
Immunohistochemistry
Sections were washed briefly with PBS/0.1% BSA (Sigma-
Aldrich). For fluorescence double immunohistochemistry, sections
were first blocked with 10% Normal Goat Serum (Invitrogen,
Carlsbad, CA) in PBS and 0.3% Triton X-100 (with the exception
of surface antigens, where Triton X-100 was omitted). Some
antibodies required a pretreatment step as follows: 30 min in 2N
HCl at 25uC for Brdu; 3 min in 100% acetone at 220uC for
human nuclear antigen. Primary antibodies were incubated
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overnight at 4uC. Appropriate secondary antibodies and fluoro-
chromes (Alexa conjugates (Molecular Probes, Invitrogen) were
applied for 1 h at 25uC followed by PBS washes, DAPI (Molecular
Probes) counterstain and mounted in glycerol. The primary
antibodies included: rat anti-Brdu (1:40, Abcam, Cambridge, UK);
Calretinin(1:2000, Swant, Bellinzona, Switzerland); Calbin-
din(1:1000, Swant); EGFR(1:100; Santa Cruz Biotechnology,
Santa Cruz, CA),PSA-NCAM (1:800, Millipore); Nestin (1:200
Millipore); CD24 (1:100, BD Pharmingen, San Diego, CA); Dlx2
(1:200 Abcam, Cambridge, CA); Tuj-1(Covance 1:200, Princeton,
NJ); human NCAM (Eric-1, 1:100, Santa Cruz Biotechnology);
and human nuclear antigen (1:50 Chemicon), GFAP(1:5,000;
Dako, Carpineria, CA), NG2 (1:100; Chemicon), DCX (1:500
Abcam), O4 (1:200 Millipore).
Quantification
Graft volumes were estimated using the Cavalieri estimator
probe (StereoInvestigator-6, MBF Bioscience, Williston, VT).
Total cell number was assessed in the graft core. Systematic
random sampling was applied to the regions of interest (graft core
and areas of distribution of human cells) as defined on serial
sections. The stereological software was used to design and
implement the fractionator probes at a coefficient of error
(Gunderson) of #0.1.
Supporting Information
Figure S1 (a) Immunocytochemical characterization of hiPS cell
lines and H9 line for the expression of the pluripotency markers
Tra1-60, Nanog, Oct4 and SSEA-4. (b) Immunofluorescence
staining of neural precursors derived from four different hiPS
clones and H9 line. Neural precursor cells (NPCs) at 50 days in
vitro show high expression of Nestin and Pax6. Scale bars, 20mm.
(TIF)
Figure S2 hES or hiPS derived oligodendrocyte precursor cells
used for grafting were immunolabeled for the oligodendrocyte cell
surface marker O4 (hNCAM/O4) while the markers specific for
SVZ type A cells (hNCAM/Dlx2), type B (hNCAM/hEGFR) or
type C cells (hNA/Dcx), were absent. O4 cells co-labeled for
Olig2. Nuclear counterstain (DAPI) in blue. Scale bar, 20mm.
(TIF)
Figure S3 In vitro immunocytochemistry of hES and hiPS
derived neural precursors for phenotypic markers of the SVZ.
NPCs (hiPS4) 50 days old were mostly immunoreactive for Nestin
and Tuj1 with a low percentage of doublecortin (Dcx) expressing
cells. At this stage, neural precursors were negative for markers
specific for SVZ type A cells (Dlx2/CD24), type B (hEGFR/
GFAP) or SVZ type C cells (hEGFR/Dlx2). Scale bar, 20mm.
(TIF)
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